Scientists identify brain circuit for chronic pain transition

Researchers at the University of Colorado Boulder have pinpointed a brain region called the caudal granular insular cortex, or CGIC, that acts as a switch turning acute pain into chronic pain. In animal studies, disabling this circuit prevented chronic pain from developing or reversed it once established. The findings, published in the Journal of Neuroscience, open paths to new treatments beyond opioids.

A team led by Linda Watkins, a distinguished professor of behavioral neuroscience at the University of Colorado Boulder, studied the CGIC in rats with sciatic nerve injuries. They used advanced chemogenetic methods and fluorescent proteins to track and silence specific neurons. Shutting down the CGIC pathway stopped pain signals from persisting after the injury healed, eliminating symptoms like allodynia, where light touch feels painful. Watkins stated, 'If this crucial decision maker is silenced, chronic pain does not occur. If it is already ongoing, chronic pain melts away.'

Relaterede artikler

Illustration of distant astrocytes signaling via CCN1 protein to enhance microglia debris clearance in mouse spinal cord injury.
Billede genereret af AI

Cedars-Sinai study maps how distant astrocytes help microglia clear debris after spinal cord injury

Rapporteret af AI Billede genereret af AI Faktatjekket

Scientists at Cedars-Sinai Medical Center report that a subset of astrocytes located away from a spinal cord injury can help drive repair in mice by releasing the protein CCN1, which alters microglia metabolism to improve cleanup of lipid-rich nerve debris. The work, published in Nature, also found evidence of a similar CCN1-linked response in human spinal cord tissue from people with multiple sclerosis.

Researchers at the University of Technology Sydney report that inducing localized inflammation in a striatal region involved in action selection pushed rats toward more goal-directed, outcome-sensitive behavior rather than automatic habits. The team traced the effect to disrupted astrocyte function, a finding they say could inform future approaches to compulsive disorders such as OCD and addiction.

Rapporteret af AI

Researchers are revisiting substance P, a neuropeptide linked to migraine pain, after it was dismissed as a treatment target 25 years ago. A recent study shows it causes headaches and blood vessel dilation in both migraine sufferers and others, suggesting potential for new therapies. This comes amid advances in blocking other migraine-related peptides like CGRP and PACAP.

Researchers at Oregon Health & Science University have pinpointed specific sites on NMDA receptors targeted by harmful antibodies in a rare autoimmune brain disorder known as "Brain on Fire." This discovery, published in Science Advances, could lead to more precise treatments and earlier detection. The condition affects about 1 in 1 million people annually, mainly young adults, causing severe symptoms like seizures and memory loss.

Rapporteret af AI

Researchers have discovered that psychedelic substances suppress visual processing in the brain, leading to hallucinations by drawing on memory fragments. The study, conducted using advanced imaging on mice, shows how slow brain waves shift perception toward internal recall. These findings could inform therapies for depression and anxiety.

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis